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Can a urine dipstick test be used to assess smoking status in patients 
undergoing planned orthopaedic surgery? A prospective cohort study 
 
Abstract  
Smoking is associated with post-surgical complications but smokers often under-report their 
smoking. Our objective was to determine whether a urine dipstick test could be used as a substitute 
for quantitative cotinine assays to determine smoking status in patients. We conducted a 
prospective cohort study over a 10 month period in which 127 consecutive patients undergoing 
planned foot and ankle arthrodesis or osteotomy were included. Patients self-reported their 
smoking status and were classified as: ‘never smoked’ (61 patients), ‘ex-smoker’ (46 patients), or 
‘current smoker’ (20 patients).  Urin  samples were analysed with cotinine assays and cotinine 
dipstick tests. There was a high degree of concordance between dipstick and assay results (Kappa 
coefficient = 0.842, p < 0.001). Compared to the quantitative assay, dipstick had a sensitivity of 
88.9% and a specificity of 97.3%. Patients claiming to have stopped smoking just prior to surgery had 
the highest rate of disagreement between reported smoking status and urine testing. Urine cotinine 
dipstick testing is cheap, fast, reliable, and easy to use. It may be used in place of quantitative assays 
as a screening tool for detecting patients who may be smoking. A positive test may be used as a 
trigger for further assessment and counselling. 
 
Introduction: 
Smokers are at increased risk of post-surgical complications.
1-4
 Nicotine causes peripheral 
vasoconstriction through its adrenergic effects and this is exacerbated by the carbon monoxide 
present in cigarette smoke. This results in reduced blood flow and decreased oxygen perfusion of 
subcutaneous tissues,
5
 which increases the risk of poor wound healing and infection.
6
  Nicotine also 
reduces the expression of bone morphogenic proteins (BMP-2) in osteoblasts which, combined with 
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reduced blood flow, impairs bone healing.
7,8
 Abstinence from smoking for a period of 4 to 8 weeks 
prior to surgery has been shown to reduce these risks.
9-12
 Smoking status is therefore particularly 
pertinent in planned surgery, where there is the opportunity for pre-operative counselling and 
cessation.
13
 Patients are often not aware of the potential adverse impact of smoking on surgical 
outcomes
14
 and following appropriate counselling a significant proportion of patients will stop or 
reduce smoking prior to surgery.
13,15
  
 
However, many patients under-report tobacco consumption.
16-18
 These are often patients with low 
to intermediate levels of education
19
 who may fear their surgery will be postponed if they admit to 
smoking. Self-reporting is therefore not an accurate means of assessing smoking status
16
 and various 
biochemical tests may be employed to confirm smoking status objectively. Serum cotinine is one 
such test and raised serum cotinine levels have been associated with post-surgical wound 
complications.
20
 Other well validated tests include urinary and salivary cotinine assays which are 
highly sensitive and specific when appropriate cut-off values are used for analysis.
21,22
 However, 
these tests require specialised equipment and are not widely available. Salivary and urinary dipstick 
tests are a cheaper, more accessible alternative to cotinine assays which may also be used in 
screening of smoking status.
23,24
  
 
Our primary research question was to determine whether a simple point of care urine dipstick test 
could be used as a substitute for quantitative urine cotinine assays to determine smoking status in 
patients undergoing planned orthopaedic surgery.  
 
Patients and Methods: 
This was a single-centre prospective cohort study on all adult patients undergoing planned 
osteotomies or arthrodesis procedures in our tertiary Foot and Ankle unit. The protocol for this 
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study was approved by the National Health Service (NHS) Research Ethics Committee (ref: 
13/LO/0670, date: 14/05/2013).
25
 All data was collected in a study specific database.  
 
Over a 10 month period, between September 2013 and July 2014, 515 patients were admitted for 
planned surgery and all were assessed for inclusion in our study. All patients were given verbal 
advice to stop smoking at their outpatient and pre-assessment clinic attendances, although the trust 
did not offer smoking cessation programmes.  
 
Inclusion criteria consisted of sequential patients booked for arthrodesis or osteotomy of the foot 
and/or ankle, who were under the care of one of three named consultant orthopaedic surgeons. 
Patients were excluded if they were under 16 years of age, if they were unable to provide informed 
consent, or if their operation did not involve an arthrodesis or osteotomy. Of the 515 admissions 
during the study period, 197 patients were deemed eligible for the study. On the morning of 
admission, eligible patients were approached with an information sheet and invited to participate in 
the study; 45 patients were not approached either because of time constraints or because the main 
investigator was unavailable.  Nine patients declined to participate. Patients were further excluded if 
they were unable to provide a urine specimen or there was a change to the planned procedure. 
(Figure 1) 
 
Once informed consent was obtained, patients were asked to complete a short questionnaire 
regarding their smoking status. (Table 1) Based on their responses patients were assigned to one of 
the following groups: ‘never smoked’, ‘ex-smoker’, or ‘current smoker’. A urine sample was also 
obtained and collected in a specimen pot, labelled with the patient number and study identification.  
 
Two cotinine level testing methods were performed for each sample: a urine dipstick test and a 
urine laboratory assay. The dipstick test used was the COT One Step Cotinine Test Device which has 
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a positive reading for cotinine concentrations above 200 ng/ml.
26
 The test yields a positive / negative 
result within three minutes of administration. This test was performed on the ward within two hours 
of sample collection and the result recorded. The remainder of the urine sample was frozen onsite 
and stored at -20 degrees Celsius prior to transport to an offsite laboratory for direct quantitative 
measurements of the cotinine levels. Urinary cotinine concentrations were determined using the 
Dynex DS2® analyser (DYNEX Technologies Ltd, Worthington, UK), and an Alere™ Toxicology 
(Abingdon, UK, formerly Concateno) urine cotinine assay which is an enzyme-linked immunosorbent 
assay (ELISA). Samples were analysed twice and the mean recorded.  
 
There is no well-defined cut-off for urinary cotinine (as measured by ELISA) to distinguish smokers 
from non-smokers. Active smokers may have urinary cotinine levels >1000 ng/ml whereas non-
smokers may have levels <50 ng/ml.
16,27
 These numbers vary with populations studied and exposure 
to passive smoke. In this study we have used an ELISA assay cut-off of 500 ng/ml to distinguish active 
smokers from non-smokers and passive smokers.
28,29
 A quantitative value of > 500 ng/ml is therefore 
taken to represent a positive test.  
 
The hospital number, gender, age, co-morbidities and operative procedure were recorded for each 
patient. Patients were followed up post operatively at weeks 2, 6, 12, 24 and 52, or until union, with 
extra appointments for those with clinical concerns. At each follow-up appointment any 
complications and progress toward union was recorded. This was the routine follow-up for all 
patients having the same type of surgery within our department. Non-union was diagnosed when 
there was no radiographic evidence of progression toward union over a three month period and at 
least 6 months had elapsed since surgery. Infections were managed according to the National 
Institute of Health and Care Excellence (NICE) guidelines.
30
  
 
Statistical analysis and sample size estimation:  
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Statistical analysis was performed using SPSS 22.0 (IBM, New York, USA). Shapiro-Wilks test for 
normality was performed which confirmed all continuous data was parametric (p < 0.001). 
Significance of the observed difference in means of continuous data between patient subgroups was 
calculated using an independent samples t-test.  An ANOVA test was performed to analyse 
differences in age and assay levels between subgroups of patients (smokers, non-smokers and ex-
smokers).  Independent categorical data were analysed using a Chi-squared test. Correlations were 
analysed using Pearson’s product moment correlation. Means are presented with a standard 
deviation. The Kappa coefficient was calculated for agreement between the results of the 
quantitative assay and the dipstick test. A 2-tailed p-value of less than 0.05 was considered 
statistically significant.  
 
A priori power calculation was performed using G*Power© v3.1.7 (Universität Kiel, Germany). 
Previous literature detailing under-reporting of smoking suggests under-reporting of 7-25%.
18,19,31
. 
This data suggested an effect size of w=0.34 to 0.63. Using a 2-tailed alpha of 0.05 and a Power (1-
beta) of 0.8 the total sample size required was calculated as 114 to 32 patients respectively. We 
therefore estimated 120 patients would be sufficient to adequately assess our study question. Based 
on previous local audits we felt 10 months of data collection would be sufficient.  
 
Results: 
One hundred and twenty-seven patients were included over the 10 month period. No patients 
withdrew and no patients were lost to follow-up. The mean age of participants was 55.68 ± 13.72 
years (range: 20 to 82 years). Seventy-nine patients were female and 48 were male. Forefoot 
osteotomy or fusion was performed in 58 patients, midfoot surgery in 10 patients, and hindfoot 
surgery in 59 patients. Mean follow-up for all patients was 52.09 ± 17.18 weeks (range: 12 to 104 
weeks).  
Page 10 of 26
https://mc04.manuscriptcentral.com/bjj
The Bone & Joint Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
6 
 
 
Sixty one patients (48.0%) stated they never smoked, 20 patients (15.8%) admitted to being current 
smokers, and 46 patients (36.2%) stated they were not currently smoking although they had smoked 
in the past. Of those who claimed to be ex-smokers, 15 (32.6%) stated they stopped smoking over 10 
years ago, 22 (47.8%) stated they had stopped over a year ago, and 9 (19.6%) stated they had 
stopped in the few weeks / months preceding their surgery. (Table 2) Amongst current smokers, the 
mean reported cigarettes smoked was 9.2 ± 10.16 cigarettes / day (range: <1 to 40 cigarettes / day). 
There was no difference in gender distribution or region operated on between smokers, non-
smokers and ex-smokers. Smokers were significantly younger (mean age: 47.75 ± 13.56 years) than 
self-reported non-smokers (mean age: 56.57 ± 14.71 years) and ex-smokers (mean age: 57.93 ± 
11.26 years, p = 0.016). There was no difference in complication or union rate between groups.  
 
An ANOVA test revealed a significant difference in mean cotinine assay levels between smokers 
(5486.30 ± 10,238.43 ng/ml), non-smokers (94.89 ± 103.52 ng/ml) and ex-smokers (254.02 ± 720.39 
ng/ml, p < 0.001). A positive dipstick was obtained in 19 (15.0%) patients, and these patients had a 
mean cotinine assay of 6086 ± 10310 ng/ml. This was significantly higher than patients with a 
negative dipstick (mean of 107 ± 155 ng/ml, p < 0.001). There was a significant correlation between 
assay level and reported number of cigarettes smoked per day: Pearson product moment correlation 
coefficient of r=0.719, p < 0.001.  
 
All reported non-smokers had a negative dipstick result, and only 1 (1.6%) had a positive assay (580 
ng/ml). No reported ex-smoker who claimed to have stopped smoking over a year prior tested 
positive on dipstick or assay. Of the 9 (19.6%) patients who claimed to have stopped smoking in the 
weeks preceding surgery, 4 had a positive dipstick test and 3 had a positive assay test. None of these 
patients reported passive smoking. Five reported current smokers (26.3%) had a negative dipstick 
and 6 (31.6%) had a negative assay test. Five of these patients reported themselves as current 
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smokers, but said they only smoked occasionally / socially. The other 2 patients reported smoking 1 
to 5 cigarettes a day.  These results are summarised in Table 3 and Figure 2.  
 
There was a high degree of agreement between the results of the urine dipstick test and the 
quantitative ELISA assessment (Kappa coefficient = 0.842, p < 0.001). In total there were only 5 
(3.93%) cases where the dipstick and assay results differed. (Table 3) Table 4 demonstrates our 
achieved sensitivity/specificity, and positive/negative predictive values for the urine dipstick test as 
compared to the quantitative assay. 
 
Discussion: 
Our research objective was to establish whether a point of care urine dipstick test could be used in 
place of a quantitative urine assay to detect patients who smoke. We performed both urine dipstick 
and assay tests on all patients. There was a very high correlation between the results of both tests 
indicating that the urine dipstick is as effective as the assay. 
 
Cotinine is a tobacco specific nicotine metabolite and has a longer half-life than nicotine and may 
therefore be detectable up to 2-3 days after nicotine consumption.
32-34
 Cotinine levels may also be 
raised by passive smoking, environmental pollution and certain foods.
35,36
 We took these factors into 
account when choosing our cut-off values. Although the dipstick uses a different cut-off point than 
the quantitative assay (200 ng/ml vs 500 ng/ml), the methods of detection differ and the results in 
both groups were found to be comparable. Urinary cotinine was used as many units routinely 
acquire a urine sample as part of pre-assessment for planned orthopaedic surgery. Semi-quantitative 
urine dipsticks have previously been validated against assays
23,37
, however, to our knowledge there 
have been no comparisons between assays and a ‘Positive/Negative’ urine dipstick test such as 
employed in this study.  
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A point of care dipstick test is easy to administer, provides a result within a matter of 3-5 minutes, 
and a single test cost us £1.50. A single quantitative assay, by contrast, cost £7.00 plus the costs of 
refrigeration and transport to an offsite laboratory. A urine dipstick test is therefore a quick, easy, 
accurate and cost-effective screening tool for detecting raised levels of urinary cotinine.  
 
The adverse of effects of smoking for patients undergoing surgery are well documented. Sorensen 
performed a meta-analysis on almost 500,000 patients across surgical specialities and demonstrated 
odds ratios of 3.6 for wound necrosis, 2.07 for delayed wound healing, 2.27 for other wound 
complications, and 1.79 for surgical site infection.
1
 This also holds true in foot and ankle surgery.
38-40
 
Raised serum cotinine concentration has been shown to predict wound complications in head and 
neck surgery,
20
 however, there is no other literature exploring the link between urinary cotinine 
concentration and complications. In our series, as expected, urinary cotinine concentration 
increased with number of cigarettes smoked but we did not observe an increased complication or 
non-union rate amongst smokers or those with high cotinine assays. However, the proportion of 
smokers in our cohort was very low and we did not assess for confounding factors such as co-
morbidities which would impact on complication rate. This study cannot therefore assess the 
relationship between urinary cotinine concentration and complications. Nevertheless, routine 
monitoring of assay levels prior to surgery is probably not cost effective, and should be reserved for 
higher risk patients identified by screening (those with a positive urine dipstick result).   
 
Smoking cessation can reduce the risks of complications
1,9
 and pre-operative counselling has been 
shown to reduce smoking both prior to, and after surgery.
13
 All patients who smoke should therefore 
be counselled to stop smoking prior to surgery, and in some cases surgery may be delayed until this 
is achieved. However, patients often under-report their tobacco consumption.
17-19,31
 In particular, 
patients who describe themselves as ex-smokers have a higher incidence of under-reporting.
41
 Our 
findings concur with the literature. No non-smokers had a positive dipstick test and patients 
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admitting to being current smokers had a positive dipstick result in most cases. The few patients 
with negative results were only occasional smokers and the negative test may be due to 
coincidentally not having smoked prior to assessment. Majority of reported ex-smokers had only 
ever smoked in their youth, or had given up smoking a number of years previously. None of these 
patients tested positive. However, amongst the 9 patients who stated they had given up smoking for 
the surgery, 4 (44%) tested positive for smoking.  
 
Patients claiming they had only recently given up smoking therefore had the highest proportion of 
contradictory cotinine assays and this is the patient group of greatest interest to the orthopaedic 
surgeon. It is likely that this group may be larger in normal practice as in this study, patients were 
aware their answers would be validated with a biochemical test.  
 
This study has limitations. Patients are categorised by self-reported smoking status which may be 
inaccurate. Validity of the urine dipstick is compared to a quantitative cotinine assay, but it is not 
possible to confirm patients with a positive assay were under-reporting their smoking, as cotinine 
levels can be raised for other reasons as discussed. Although there was a good correlation between 
our dipstick and assay results, there may have been an error in choosing our assay cut-off point. We 
aimed to minimise this by using values previously reported as reliable, but consensus in the 
literature is poor. It is also likely that as patients were enrolled in a study, they were more honest 
with their answers than would be seen in normal practice. Strengths of our study include a 
prospective study design with a priori power calculation to determine number of patients required, 
which was achieved. We used validated assessment tools, the results of which strongly correlated. 
We repeated each assay twice to improve accuracy and tested for confounding demographic factors.  
 
In conclusion, dipstick testing for urinary cotinine is cheap, fast, reliable, and easy to use. It may be 
used in place of quantitative assays as a screening tool for detecting patients suspected of under-
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reporting their smoking. It has a high specificity and negative predictive value and therefore a 
negative result strongly suggests the patient is not currently smoking. A positive test does not 
equate to proof of smoking but may be used as a trigger for further assessment and counselling.  
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Figure Captions: 
Figure 1: Flow chart demonstrating the recruitment of participants. No patients were lost to 
follow-up 
 
Figure 2: Results of ELISA urine assay and urine dipstick tests by smoking status. A positive 
quantitative cotinine assay was taken as greater than 500 ng/ml. For all groups, there was good 
correlation between the results of the dipstick test and assays (Kappa = 0.842, p < 0.001).  
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Table 1: 
Questionnaire patients were asked to complete regarding their smoking behaviour / status. 
 
Question Response 
Have you ever smoked cigarettes / tobacco? Yes / No 
If ‘Yes’, do you currently smoke? Yes / No 
How many cigarettes do you smoke per day? ________ 
How many years have you smoked for? ________ 
If you no longer smoke, how long ago did you stop smoking? ________ 
Are you exposed to smoking in your home / work environment? Yes / No 
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Table 2: 
Patient reported smoking status. Duration since cessation listed for reported ex-smokers and 
number of cigarettes smoked per day listed for reported current smokers.  
 
Never Smoked Ex-Smoker Current Smoker 
Number  
(Percentage) 
61 
(48.0%) 
46 
(36.2%) 
20 
(15.8%) 
Report Stopping:  
> 10 years ago 
- 
15 
(32.6%) 
- 
Report Stopping:  
1 – 10 years ago 
- 
22 
(47.8%) 
- 
Report Stopping: 
Weeks prior to surgery 
- 
9 
(19.6%) 
- 
Report smoking:  
< 1 / day 
- - 
4 
(20.0%) 
Report smoking:  
1-10 / day 
- - 
10 
(50.0%) 
Report smoking:  
11-20 / day 
- - 
4 
(20.0%) 
Report smoking:  
> 20 / day 
- - 
2 
(10.0%) 
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Table 3: 
Results of urine assay and dipstick per category of patients. Where annotated ‘*’ assay and dipstick 
results are not in agreement.   
 
Assay  
Result 
Dipstick  
Result 
Non-Smoker 
Ex-Smoker  
(> 1 year) 
Ex-Smoker  
(< 1 year) 
Current  
Smoker 
< 500 ng/ml -ve dipstick 60 37 5 4 
 +ve dipstick - - 1* 2* 
> 500 ng/ml -ve dipstick 1* - - 1* 
 +ve dipstick - - 3 13 
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Table 4: 
Results of urine dipstick tests compared to patient reported smoking status and smoking status as 
determined by urine cotinine assay. The urine cotinine assay was considered positive if the value 
was > 500 ng/ml. The data in this table assumes patients’ description of themselves as ‘ex-smokers’ 
was accurate.  
 
                      
  Urine Dipstick Result versus  
Reported Smoking Status 
 
Urine Dipstick Result versus  
Urine Cotinine Assay 
  
                  
  
  Smoker Non-Smoker Total     >500ng/ml <500ng/ml Total 
  
  
+ve test 15 4 19   +ve test 16 3 19 
  
  
-ve test 5 103 108   -ve test 2 106 108 
  
  
Total 20 107 127   Total 18 109 127 
  
                     
  
Sensitivity: 75.00%  Sensitivity: 88.89% 
  
  
Specificity: 96.26%  Specificity: 97.25% 
  
  
Positive Predictive Value: 78.95%  Positive Predictive Value: 84.21% 
  
  
Negative Predictive Value: 95.37%  Negative Predictive Value: 98.15% 
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Figure 1: Flow chart demonstrating the recruitment of participants. No patients were lost to follow-up  
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Figure 2: Results of ELISA urine assay and urine dipstick tests by smoking status. A positive quantitative 
cotinine assay was taken as greater than 500 ng/ml. For all groups, there was good correlation between the 
results of the dipstick test and assays (Kappa = 0.842, p < 0.001).  
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